Future Impact of mRNA Therapy on Cardiovascular Diseases
The silver lining of the recent pandemic was that it accelerated the emergence of messenger ribonucleic acid (mRNA) therapeutics. The great promise of mRNA therapeutics was highlighted by the speed at which the vaccines were created, tested, and proven to be relatively safe and highly effective. The...
Saved in:
| Main Authors: | John P. Cooke, Keith A. Youker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2022-12-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1169 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CARDIOVASCULAR EFFECTS OF DUAL VACCINATION WITH PNEUMOCOCCAL PV23 AND INFLUENZA: A SYSTEMATIC REVIEW
by: Sotelo-Velasquez Yulied Angie, et al.
Published: (2024-12-01) -
Cardiac arrhythmia following acute myocardial infarction: a retrospective analysis of 27,648 hospitalized patients in a tertiary heart hospital
by: Nidal Asaad, et al.
Published: (2025-04-01) -
Cardiovascular manifestations in COVID-19 patients
by: Jyotsna Maddury, et al.
Published: (2022-01-01) -
Educational Attainment Level and Risk of Mortality and Cardiopulmonary Outcomes in High‐Risk Patients With Cardiovascular Disease: The INVESTED Trial
by: Mats C. H. Lassen, et al.
Published: (2025-07-01) -
Left Ventricular Pseudoaneurysm (LVP) a Rare Mechanical Complication after Acute Myocardial Infarction
by: Satish R. Chirde, et al.
Published: (2025-07-01)